136 related articles for article (PubMed ID: 36438475)
1. Erratum: Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway: Erratum.
Liu HJ; Qin Y; Zhao ZH; Zhang Y; Yang JH; Zhai DH; Cui F; Luo C; Lu MX; Liu PP; Xu HW; Li K; Sun B; Chen S; Zhou HG; Yang C; Sun T
Theranostics; 2022; 12(17):7645. PubMed ID: 36438475
[TBL] [Abstract][Full Text] [Related]
2. Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.
Liu HJ; Qin Y; Zhao ZH; Zhang Y; Yang JH; Zhai DH; Cui F; Luo C; Lu MX; Liu PP; Xu HW; Li K; Sun B; Chen S; Zhou HG; Yang C; Sun T
Theranostics; 2020; 10(20):9083-9099. PubMed ID: 32802180
[No Abstract] [Full Text] [Related]
3. Erratum: Microglial TLR4-dependent autophagy induces ischemic white matter damage via STAT1/6 pathway: Erratum.
Qin C; Liu Q; Hu ZW; Zhou LQ; Shang K; Bosco DB; Wu LJ; Tian DS; Wang W
Theranostics; 2020; 10(19):8818-8820. PubMed ID: 32754280
[TBL] [Abstract][Full Text] [Related]
4. Erratum: Inflammatory extracellular vesicles prompt heart dysfunction via TLR4-dependent NF-κB activation: Erratum.
Biemmi V; Milano G; Ciullo A; Cervio E; Burrello J; Dei Cas M; Paroni R; Tallone T; Moccetti T; Pedrazzini G; Longnus S; Vassalli G; Barile L
Theranostics; 2023; 13(4):1286. PubMed ID: 36923528
[TBL] [Abstract][Full Text] [Related]
5. Lentinan-functionalized selenium nanosystems with high permeability infiltrate solid tumors by enhancing transcellular transport.
Yang F; Huang J; Liu H; Lin W; Li X; Zhu X; Chen T
Nanoscale; 2020 Jul; 12(27):14494-14503. PubMed ID: 32614349
[TBL] [Abstract][Full Text] [Related]
6. Erratum: Enhanced Blood Suspensibility and Laser-Activated Tumor-specific Drug Release of Theranostic Mesoporous Silica Nanoparticles by Functionalizing with Erythrocyte Membranes: Erratum.
Su J; Sun H; Meng Q; Zhang P; Yin Q; Li Y
Theranostics; 2020; 10(5):2401. PubMed ID: 32104511
[TBL] [Abstract][Full Text] [Related]
7. Erratum: Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles: Erratum.
Zhou Z; Zhang B; Wang H; Yuan A; Hu Y; Wu J
Theranostics; 2020; 10(7):2943. PubMed ID: 32194846
[TBL] [Abstract][Full Text] [Related]
8. Erratum: A cell-penetrating whole molecule antibody targeting intracellular HBx suppresses hepatitis B virus via TRIM21-dependent pathway: Erratum.
Zhang JF; Xiong HL; Cao JL; Wang SJ; Guo XR; Lin BY; Zhang Y; Zhao JH; Wang YB; Zhang TY; Yuan Q; Zhang J; Xia NS
Theranostics; 2022; 12(8):3601. PubMed ID: 35664069
[TBL] [Abstract][Full Text] [Related]
9. Lentinan-functionalized selenium nanoparticles induce apoptosis and cell cycle arrest in human colon carcinoma HCT-116 cells.
Gao X; Yao Y; Chen X; Lin X; Yang X; Ho CT; Li B; Chen Z
Front Nutr; 2022; 9():987807. PubMed ID: 36082027
[TBL] [Abstract][Full Text] [Related]
10. Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum.
Li F; Li X; Li Z; Ji W; Lu S; Xia W
Theranostics; 2023; 13(13):4391. PubMed ID: 37649610
[TBL] [Abstract][Full Text] [Related]
11. Erratum: Cancer-associated Fibroblast-derived IL-6 Promotes Head and Neck Cancer Progression via the Osteopontin-NF-kappa B Signaling Pathway: Erratum.
Qin X; Yan M; Wang X; Xu Q; Wang X; Zhu X; Shi J; Li Z; Zhang J; Chen W
Theranostics; 2022; 12(4):1730-1731. PubMed ID: 35198066
[TBL] [Abstract][Full Text] [Related]
12. Erratum: Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas: Erratum.
Lei HM; Zhang KR; Wang CH; Wang Y; Zhuang GL; Lu LM; Zhang J; Shen Y; Chen HZ; Zhu L
Theranostics; 2023; 13(7):2257-2258. PubMed ID: 37153741
[TBL] [Abstract][Full Text] [Related]
13. Erratum: In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell: Erratum.
Hu K; Yin F; Yu M; Sun C; Li J; Liang Y; Li W; Xie M; Lao Y; Liang W; Li ZG
Theranostics; 2018; 8(20):5660-5661. PubMed ID: 30555571
[TBL] [Abstract][Full Text] [Related]
14. Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum.
Li F; Li X; Li Z; Ji W; Lu S; Xia W
Theranostics; 2020; 10(12):5528-5529. PubMed ID: 32373227
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Preventing tumor progression to the bone by induced tumor-suppressing MSCs: Erratum.
Sun X; Li K; Zha R; Liu S; Fan Y; Wu D; Hase M; Aryal UK; Lin CC; Li BY; Yokota H
Theranostics; 2022; 12(14):6155-6156. PubMed ID: 36168625
[TBL] [Abstract][Full Text] [Related]
16. Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum.
Li L; Xu J; Qiu G; Ying J; Du Z; Xiang T; Wong KY; Srivastava G; Zhu XF; Mok TS; Chan AT; Chan FK; Ambinder RF; Tao Q
Theranostics; 2022; 12(4):1736-1737. PubMed ID: 35198069
[TBL] [Abstract][Full Text] [Related]
17. Erratum: NLRP3 inflammasome
Ding Z; Wang X; Liu S; Zhou S; Kore RA; Mu S; Deng X; Fan Y; Mehta JL
Theranostics; 2022; 12(1):418. PubMed ID: 34987654
[TBL] [Abstract][Full Text] [Related]
18. Erratum: CDC20 regulates cardiac hypertrophy via targeting LC3-dependent autophagy: Erratum.
Xie YP; Lai S; Lin QY; Xie X; Liao JW; Wang HX; Tian C; Li HH
Theranostics; 2021; 11(20):10173. PubMed ID: 34815811
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Dual target gene therapy to EML4-ALK NSCLC by a gold nanoshell-based system: Erratum.
Li S; Liu Y; Rui Y; Tang L; Achilefu S; Gu Y
Theranostics; 2020; 10(5):2402-2404. PubMed ID: 32104512
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.
Zhao Z; Li L; Du P; Ma L; Zhang W; Zheng L; Lan B; Zhang B; Ma F; Xu B; Zhan Q; Song Y
Theranostics; 2023; 13(4):1287-1288. PubMed ID: 36923525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
